ClinVar Miner

Submissions for variant NM_014363.6(SACS):c.604+1G>A

dbSNP: rs1555254734
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000666450 SCV000790745 likely pathogenic Charlevoix-Saguenay spastic ataxia 2017-04-06 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV003750811 SCV004551692 likely pathogenic Spastic paraplegia 2023-02-02 criteria provided, single submitter clinical testing In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 551399). Disruption of this splice site has been observed in individual(s) with autosomal recessive spastic ataxia of Charlevoix-Saguenay (PMID: 30638817). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 7 of the SACS gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SACS are known to be pathogenic (PMID: 18465152, 20876471).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.